STILPANE

BREAK OUT OF THE PAIN LIVE AGAIN. STILPANE

Relief of short term pain associated with anxiety and tension – Effective in acute and post-operative pain treatment1 • STILPANE has a trusted legacy • STILPANE offers a significant cost saving*2 • STILPANE capsules are more suitable for CV** or GI# sensitive patients as they are without caffeine-

Recommended dosage: • 2 capsules/tablets 3-4 times per day • Do not exceed maximum dose • Not recommended in children < 12 years of age

STILPANE is indicated for short term use (no longer than 5 days) in mild to moderate pain.

CONTRAINDICATIONS STILPANE is contraindicated in: • Hypersensitivity to any of the active ingredients or excipients of STILPANE (see COMPOSITION). • Porphyria (including acute forms of porphyria, especially variegate porphyria, acute intermittent porphyria and hereditary coproporphyria). • Pregnancy and lactation (see HUMAN REPRODUCTION). • Patients with severe liver or kidney complications. • Pulmonary insufficiency. • STILPANE may induce convulsions in patients with a history of epilepsy. • Obstructive airways disease, respiratory depression, especially in the presence of cyanosis and excessive bronchial secretion. • After operations on the biliary tract. • Acute alcoholism.

Head injuries and conditions in which intracranial pressure is raised. • Comatose patients. • During an attack of bronchial asthma or in heart failure secondary to chronic lung disease. • Patients taking monoamine oxidase inhibitors or within fourteen days of stopping such treatment (see INTERACTIONS).

WARNINGS AND SPECIAL PRECAUTIONS

STILPANE contains paracetamol which may be fatal in overdose. In the event of overdosage or suspected overdose and notwithstanding the fact that the person may be asymptomatic, the nearest doctor, hospital or Poison Centre must be contacted immediately.

Meprobamate

STILPANE should not be used for periods longer than 5 days. Patients receiving meprobamate as contained in STILPANE should be warned that their tolerance to ingested alcohol and other depressants of the central nervous system may be lowered with consequent impairment of judgment and co-ordination. STILPANE should be avoided in elderly and debilitated patients and in those with mental depression.

STILPANE should be used with caution in patients with impaired hepatic or renal function, and as with all sedatives, in patients with impaired respiratory functions.